nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—Hallucination—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Pergolide—Pain—Fludarabine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Pergolide—Constipation—Fludarabine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Pergolide—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Pergolide—Vasculitis—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Pergolide—Respiratory failure—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Pergolide—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Pergolide—Eye disorder—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Pergolide—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Pergolide—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Pergolide—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Pergolide—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Pergolide—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Pergolide—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Pergolide—Anaemia—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Pergolide—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Pergolide—Asthenia—Teniposide—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Pergolide—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Pergolide—Melaena—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Pergolide—Malaise—Bleomycin—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Pergolide—Pruritus—Teniposide—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Pergolide—Arrhythmia—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Pergolide—Leukopenia—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Pergolide—Cystitis—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Pergolide—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Pergolide—Alopecia—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Pergolide—Body temperature increased—Fludarabine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Pergolide—Vaginal infection—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Pergolide—Cough—Bleomycin—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Pergolide—Diarrhoea—Teniposide—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Pergolide—Myalgia—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Pergolide—Chest pain—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Pergolide—Alopecia—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Pergolide—Coma—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Pergolide—Back pain—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Pergolide—Discomfort—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Pergolide—Chills—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Pergolide—Bladder pain—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Pergolide—Neoplasm—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Pergolide—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Pergolide—Alopecia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Pergolide—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Pergolide—Confusional state—Bleomycin—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Pergolide—Tremor—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Pergolide—Oedema—Bleomycin—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Pergolide—Infection—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Pergolide—Anaemia—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Pergolide—Back pain—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Pergolide—Vomiting—Teniposide—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Pergolide—Sepsis—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Pergolide—Agitation—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Pergolide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Pergolide—Asthenia—Fludarabine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Pergolide—Rash—Teniposide—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Pergolide—Dermatitis—Teniposide—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Pergolide—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Pergolide—Headache—Teniposide—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Pergolide—Pruritus—Fludarabine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Pergolide—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Pergolide—Back pain—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Pergolide—Leukopenia—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Pergolide—Anorexia—Bleomycin—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Pergolide—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Pergolide—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Pergolide—Anaemia—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Pergolide—Agitation—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Pergolide—Hypotension—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Pergolide—Diarrhoea—Fludarabine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Pergolide—Convulsion—Carmustine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Pergolide—Hypertension—Carmustine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Pergolide—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Pergolide—Nausea—Teniposide—lymphatic system cancer	0.001	0.001	CcSEcCtD
Pergolide—Anaemia—Mitoxantrone—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Pergolide—Vertigo—Vincristine—lymphatic system cancer	0.000997	0.000997	CcSEcCtD
Pergolide—Leukopenia—Vincristine—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Pergolide—Myalgia—Carmustine—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Pergolide—Chest pain—Carmustine—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Pergolide—Anxiety—Carmustine—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Pergolide—Paraesthesia—Bleomycin—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Pergolide—Malaise—Mitoxantrone—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Pergolide—Dyspnoea—Bleomycin—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Pergolide—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000967	0.000967	CcSEcCtD
Pergolide—Convulsion—Vincristine—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Pergolide—Hypertension—Vincristine—lymphatic system cancer	0.000958	0.000958	CcSEcCtD
Pergolide—Confusional state—Carmustine—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Pergolide—Oedema—Carmustine—lymphatic system cancer	0.000948	0.000948	CcSEcCtD
Pergolide—Decreased appetite—Bleomycin—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Pergolide—Myalgia—Vincristine—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Pergolide—Cough—Mitoxantrone—lymphatic system cancer	0.000943	0.000943	CcSEcCtD
Pergolide—Infection—Carmustine—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
Pergolide—Vomiting—Fludarabine—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
Pergolide—Convulsion—Mitoxantrone—lymphatic system cancer	0.000936	0.000936	CcSEcCtD
Pergolide—Rash—Fludarabine—lymphatic system cancer	0.000934	0.000934	CcSEcCtD
Pergolide—Dermatitis—Fludarabine—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Pergolide—Hypertension—Mitoxantrone—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Pergolide—Pain—Bleomycin—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Pergolide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Pergolide—Headache—Fludarabine—lymphatic system cancer	0.000928	0.000928	CcSEcCtD
Pergolide—Tachycardia—Carmustine—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Pergolide—Chest pain—Mitoxantrone—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Pergolide—Myalgia—Mitoxantrone—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Pergolide—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Pergolide—Anxiety—Mitoxantrone—lymphatic system cancer	0.000916	0.000916	CcSEcCtD
Pergolide—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Pergolide—Discomfort—Mitoxantrone—lymphatic system cancer	0.000909	0.000909	CcSEcCtD
Pergolide—Oedema—Vincristine—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Pergolide—Anorexia—Carmustine—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Pergolide—Infection—Vincristine—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Pergolide—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000895	0.000895	CcSEcCtD
Pergolide—Confusional state—Mitoxantrone—lymphatic system cancer	0.000889	0.000889	CcSEcCtD
Pergolide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Pergolide—Hypotension—Carmustine—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Pergolide—Oedema—Mitoxantrone—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Pergolide—Nausea—Fludarabine—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Pergolide—Infection—Mitoxantrone—lymphatic system cancer	0.000876	0.000876	CcSEcCtD
Pergolide—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Pergolide—Shock—Mitoxantrone—lymphatic system cancer	0.000867	0.000867	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Pergolide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000863	0.000863	CcSEcCtD
Pergolide—Anorexia—Vincristine—lymphatic system cancer	0.000863	0.000863	CcSEcCtD
Pergolide—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Pergolide—Body temperature increased—Bleomycin—lymphatic system cancer	0.000859	0.000859	CcSEcCtD
Pergolide—Insomnia—Carmustine—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Pergolide—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Pergolide—Paraesthesia—Carmustine—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Pergolide—Mood swings—Methotrexate—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Pergolide—Hypotension—Vincristine—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Pergolide—Dyspnoea—Carmustine—lymphatic system cancer	0.000845	0.000845	CcSEcCtD
Pergolide—Somnolence—Carmustine—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Pergolide—Anorexia—Mitoxantrone—lymphatic system cancer	0.00084	0.00084	CcSEcCtD
Pergolide—Ataxia—Methotrexate—lymphatic system cancer	0.00084	0.00084	CcSEcCtD
Pergolide—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000825	0.000825	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000825	0.000825	CcSEcCtD
Pergolide—Decreased appetite—Carmustine—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Pergolide—Hypotension—Mitoxantrone—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Pergolide—Insomnia—Vincristine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Pergolide—Paraesthesia—Vincristine—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Pergolide—Constipation—Carmustine—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Pergolide—Pain—Carmustine—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Pergolide—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000792	0.000792	CcSEcCtD
Pergolide—Decreased appetite—Vincristine—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Pergolide—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Pergolide—Somnolence—Mitoxantrone—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Pergolide—Feeling abnormal—Carmustine—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Pergolide—Asthenia—Bleomycin—lymphatic system cancer	0.000779	0.000779	CcSEcCtD
Pergolide—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Pergolide—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000775	0.000775	CcSEcCtD
Pergolide—Constipation—Vincristine—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Pergolide—Pain—Vincristine—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Pergolide—Asthma—Methotrexate—lymphatic system cancer	0.000772	0.000772	CcSEcCtD
Pergolide—Pruritus—Bleomycin—lymphatic system cancer	0.000769	0.000769	CcSEcCtD
Pergolide—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000766	0.000766	CcSEcCtD
Pergolide—Eosinophilia—Methotrexate—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Pergolide—Pancreatitis—Methotrexate—lymphatic system cancer	0.000757	0.000757	CcSEcCtD
Pergolide—Pain—Mitoxantrone—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Pergolide—Constipation—Mitoxantrone—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Pergolide—Abdominal pain—Carmustine—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Pergolide—Body temperature increased—Carmustine—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Pergolide—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00074	0.00074	CcSEcCtD
Pergolide—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000727	0.000727	CcSEcCtD
Pergolide—Dysuria—Methotrexate—lymphatic system cancer	0.000722	0.000722	CcSEcCtD
Pergolide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Pergolide—Abdominal pain—Vincristine—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Pergolide—Body temperature increased—Vincristine—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Pergolide—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Pergolide—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Pergolide—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Pergolide—Pneumonia—Methotrexate—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Pergolide—Vomiting—Bleomycin—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Pergolide—Depression—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Pergolide—Rash—Bleomycin—lymphatic system cancer	0.000685	0.000685	CcSEcCtD
Pergolide—Dermatitis—Bleomycin—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Pergolide—Asthenia—Carmustine—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Pergolide—Renal failure—Methotrexate—lymphatic system cancer	0.000677	0.000677	CcSEcCtD
Pergolide—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Pergolide—Sweating—Methotrexate—lymphatic system cancer	0.00066	0.00066	CcSEcCtD
Pergolide—Haematuria—Methotrexate—lymphatic system cancer	0.000657	0.000657	CcSEcCtD
Pergolide—Epistaxis—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Pergolide—Asthenia—Vincristine—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Pergolide—Diarrhoea—Carmustine—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Pergolide—Nausea—Bleomycin—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Pergolide—Asthenia—Mitoxantrone—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Pergolide—Dizziness—Carmustine—lymphatic system cancer	0.000627	0.000627	CcSEcCtD
Pergolide—Diarrhoea—Vincristine—lymphatic system cancer	0.000619	0.000619	CcSEcCtD
Pergolide—Hepatitis—Methotrexate—lymphatic system cancer	0.000618	0.000618	CcSEcCtD
Pergolide—Pharyngitis—Methotrexate—lymphatic system cancer	0.000614	0.000614	CcSEcCtD
Pergolide—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000603	0.000603	CcSEcCtD
Pergolide—Vomiting—Carmustine—lymphatic system cancer	0.000603	0.000603	CcSEcCtD
Pergolide—Dizziness—Vincristine—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Pergolide—Rash—Carmustine—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Pergolide—Dermatitis—Carmustine—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Pergolide—Visual impairment—Methotrexate—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Pergolide—Headache—Carmustine—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Pergolide—Eye disorder—Methotrexate—lymphatic system cancer	0.000578	0.000578	CcSEcCtD
Pergolide—Tinnitus—Methotrexate—lymphatic system cancer	0.000576	0.000576	CcSEcCtD
Pergolide—Vomiting—Vincristine—lymphatic system cancer	0.000576	0.000576	CcSEcCtD
Pergolide—Rash—Vincristine—lymphatic system cancer	0.000571	0.000571	CcSEcCtD
Pergolide—Dermatitis—Vincristine—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Pergolide—Headache—Vincristine—lymphatic system cancer	0.000567	0.000567	CcSEcCtD
Pergolide—Nausea—Carmustine—lymphatic system cancer	0.000563	0.000563	CcSEcCtD
Pergolide—Vomiting—Mitoxantrone—lymphatic system cancer	0.000561	0.000561	CcSEcCtD
Pergolide—Rash—Mitoxantrone—lymphatic system cancer	0.000556	0.000556	CcSEcCtD
Pergolide—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000555	0.000555	CcSEcCtD
Pergolide—Chills—Methotrexate—lymphatic system cancer	0.000555	0.000555	CcSEcCtD
Pergolide—Headache—Mitoxantrone—lymphatic system cancer	0.000552	0.000552	CcSEcCtD
Pergolide—Alopecia—Methotrexate—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Pergolide—Nausea—Vincristine—lymphatic system cancer	0.000538	0.000538	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—lymphatic system cancer	0.000527	0.000527	CcSEcCtD
Pergolide—Nausea—Mitoxantrone—lymphatic system cancer	0.000524	0.000524	CcSEcCtD
Pergolide—Back pain—Methotrexate—lymphatic system cancer	0.000521	0.000521	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000499	0.000499	CcSEcCtD
Pergolide—Anaemia—Methotrexate—lymphatic system cancer	0.000497	0.000497	CcSEcCtD
Pergolide—Malaise—Methotrexate—lymphatic system cancer	0.000485	0.000485	CcSEcCtD
Pergolide—Vertigo—Methotrexate—lymphatic system cancer	0.000484	0.000484	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—lymphatic system cancer	0.000482	0.000482	CcSEcCtD
Pergolide—Cough—Methotrexate—lymphatic system cancer	0.00047	0.00047	CcSEcCtD
Pergolide—Convulsion—Methotrexate—lymphatic system cancer	0.000466	0.000466	CcSEcCtD
Pergolide—Myalgia—Methotrexate—lymphatic system cancer	0.000458	0.000458	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—lymphatic system cancer	0.000458	0.000458	CcSEcCtD
Pergolide—Chest pain—Methotrexate—lymphatic system cancer	0.000458	0.000458	CcSEcCtD
Pergolide—Discomfort—Methotrexate—lymphatic system cancer	0.000453	0.000453	CcSEcCtD
Pergolide—Confusional state—Methotrexate—lymphatic system cancer	0.000443	0.000443	CcSEcCtD
Pergolide—Infection—Methotrexate—lymphatic system cancer	0.000436	0.000436	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00043	0.00043	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000425	0.000425	CcSEcCtD
Pergolide—Anorexia—Methotrexate—lymphatic system cancer	0.000419	0.000419	CcSEcCtD
Pergolide—Hypotension—Methotrexate—lymphatic system cancer	0.00041	0.00041	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.0004	0.0004	CcSEcCtD
Pergolide—Insomnia—Methotrexate—lymphatic system cancer	0.000397	0.000397	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Pergolide—Somnolence—Methotrexate—lymphatic system cancer	0.00039	0.00039	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—lymphatic system cancer	0.000387	0.000387	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—lymphatic system cancer	0.000382	0.000382	CcSEcCtD
Pergolide—Pain—Methotrexate—lymphatic system cancer	0.000376	0.000376	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000362	0.000362	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000359	0.000359	CcSEcCtD
Pergolide—Abdominal pain—Methotrexate—lymphatic system cancer	0.000347	0.000347	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—lymphatic system cancer	0.000347	0.000347	CcSEcCtD
Pergolide—Asthenia—Methotrexate—lymphatic system cancer	0.000315	0.000315	CcSEcCtD
Pergolide—Pruritus—Methotrexate—lymphatic system cancer	0.000311	0.000311	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—lymphatic system cancer	0.000301	0.000301	CcSEcCtD
Pergolide—Dizziness—Methotrexate—lymphatic system cancer	0.00029	0.00029	CcSEcCtD
Pergolide—Vomiting—Methotrexate—lymphatic system cancer	0.000279	0.000279	CcSEcCtD
Pergolide—Rash—Methotrexate—lymphatic system cancer	0.000277	0.000277	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—lymphatic system cancer	0.000277	0.000277	CcSEcCtD
Pergolide—Headache—Methotrexate—lymphatic system cancer	0.000275	0.000275	CcSEcCtD
Pergolide—Nausea—Methotrexate—lymphatic system cancer	0.000261	0.000261	CcSEcCtD
